Outsourcing-Pharma and Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, Nina Vas, and Senior Director of Global Patient-Centric Service, Gaurang Majmudar, discuss the ways decentralized clinical trials (DCTs) challenge the supply chain compared to traditional trials. They examine the benefits of an experienced, single-source partner, why DCTs need a more agile supply chain and how to maintain security when shipping products directly to patients.